Hennion & Walsh Asset Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.8M | Sell |
198,514
-959
| -0.5% | -$90.7K | 0.76% | 14 |
|
|
2025
Q1 | $12.7M | Buy |
199,473
+5,766
| +3% | +$366K | 0.56% | 26 |
|
|
2024
Q4 | $9M | Buy |
193,707
+37,872
| +24% | +$1.76M | 0.41% | 41 |
|
|
2024
Q3 | $4.48M | Buy |
155,835
+20,206
| +15% | +$581K | 0.21% | 113 |
|
|
2024
Q2 | $1.96M | Buy |
135,629
+68,264
| +101% | +$987K | 0.1% | 252 |
|
|
2024
Q1 | $1.08M | Buy |
67,365
+28,071
| +71% | +$452K | 0.06% | 400 |
|
|
2023
Q4 | $781K | Buy |
+39,294
| New | +$781K | 0.04% | 467 |
|